The Valley Desk

ReviewNature reviews. Drug discoveryPublished

Safety considerations for cereblon-recruiting targeted protein degraders

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Review
Venue
Nature reviews. Drug discovery
Published
Subject terms
Animals; Humans; Thalidomide; Ubiquitin-Protein Ligases; Adaptor Proteins, Signal Transducing; Proteolysis; Immunomodulating Agents; Proteolysis Targeting Chimera
PubMed ID
42009768
Added to directory
Source checked

Report a correction or request removal